These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17712251)

  • 1. Evaluating equivalency between response systems: application of the Rasch model to a 3-level and 5-level EQ-5D.
    Pickard AS; Kohlmann T; Janssen MF; Bonsel G; Rosenbloom S; Cella D
    Med Care; 2007 Sep; 45(9):812-9. PubMed ID: 17712251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets.
    Law EH; Pickard AS; Xie F; Walton SM; Lee TA; Schwartz A
    Med Decis Making; 2018 Nov; 38(8):968-982. PubMed ID: 30403577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients.
    Pickard AS; De Leon MC; Kohlmann T; Cella D; Rosenbloom S
    Med Care; 2007 Mar; 45(3):259-63. PubMed ID: 17304084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.
    Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA
    Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare?
    Feng Y; Devlin N; Herdman M
    Health Qual Life Outcomes; 2015 Oct; 13():171. PubMed ID: 26489956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A vision 'bolt-on' increases the responsiveness of EQ-5D: preliminary evidence from a study of cataract surgery.
    Gandhi M; Ang M; Teo K; Wong CW; Wei YC; Tan RL; Janssen MF; Luo N
    Eur J Health Econ; 2020 Jun; 21(4):501-511. PubMed ID: 31902023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EQ-5D-5L is More Responsive than EQ-5D-3L to Treatment Benefit of Cataract Surgery.
    Gandhi M; Ang M; Teo K; Wong CW; Wei YC; Tan RL; Janssen MF; Luo N
    Patient; 2019 Aug; 12(4):383-392. PubMed ID: 30607809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head-to-Head Comparison of EQ-5D-3L and EQ-5D-5L Health Values.
    Selivanova A; Buskens E; Krabbe PFM
    Pharmacoeconomics; 2018 Jun; 36(6):715-725. PubMed ID: 29623559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy.
    Bhadhuri A; Kind P; Salari P; Jungo KT; Boland B; Byrne S; Hossmann S; Dalleur O; Knol W; Moutzouri E; O'Mahony D; Murphy KD; Wisselink L; Rodondi N; Schwenkglenks M
    Health Qual Life Outcomes; 2020 Sep; 18(1):317. PubMed ID: 32993637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the scaling properties of the English, Spanish, French, and Chinese EQ-5D descriptive systems.
    Luo N; Li M; Chevalier J; Lloyd A; Herdman M
    Qual Life Res; 2013 Oct; 22(8):2237-43. PubMed ID: 23266797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choice Defines QALYs: A US Valuation of the EQ-5D-5L.
    Craig BM; Rand K
    Med Care; 2018 Jun; 56(6):529-536. PubMed ID: 29668646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients.
    Poór AK; Rencz F; Brodszky V; Gulácsi L; Beretzky Z; Hidvégi B; Holló P; Kárpáti S; Péntek M
    Qual Life Res; 2017 Dec; 26(12):3409-3419. PubMed ID: 28875430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The EQ-5D-5L is More Discriminative Than the EQ-5D-3L in Patients with Diabetes in Singapore.
    Wang P; Luo N; Tai ES; Thumboo J
    Value Health Reg Issues; 2016 May; 9():57-62. PubMed ID: 27881260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients.
    Pattanaphesaj J; Thavorncharoensap M
    Health Qual Life Outcomes; 2015 Feb; 13():14. PubMed ID: 25890017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is EQ-5D-5L Better Than EQ-5D-3L? A Head-to-Head Comparison of Descriptive Systems and Value Sets from Seven Countries.
    Janssen MF; Bonsel GJ; Luo N
    Pharmacoeconomics; 2018 Jun; 36(6):675-697. PubMed ID: 29470821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation and comparison of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in Greece.
    Yfantopoulos JN; Chantzaras AE
    Eur J Health Econ; 2017 May; 18(4):519-531. PubMed ID: 27262480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the EQ-5D-3L and 5L versions in low back pain patients.
    Garratt AM; Furunes H; Hellum C; Solberg T; Brox JI; Storheim K; Johnsen LG
    Health Qual Life Outcomes; 2021 May; 19(1):155. PubMed ID: 34049574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The EQ-5D-5L index score is more discriminative than the EQ-5D-3L index score in diabetes patients.
    Pan CW; Sun HP; Wang X; Ma Q; Xu Y; Luo N; Wang P
    Qual Life Res; 2015 Jul; 24(7):1767-74. PubMed ID: 25540029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychometric Properties of EQ-5D-3L and EQ-5D-5L in Cognitively Impaired Patients Living with Dementia.
    Michalowsky B; Hoffmann W; Xie F
    J Alzheimers Dis; 2021; 83(1):77-87. PubMed ID: 34275901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the performance of the EQ-5D-3L and the EQ-5D-5L in young Portuguese adults.
    Ferreira LN; Ferreira PL; Ribeiro FP; Pereira LN
    Health Qual Life Outcomes; 2016 Jun; 14():89. PubMed ID: 27267761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.